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Objectives: Cachexia is common in pancreatic cancer and may have an influence on longterm survival
but few studies have investigated this in patients with operable tumours. Therefore, this study was carried
out to document body composition status in patients with pancreatic adenocarcinoma (PCa) presenting
for a Whipple's procedure (WP) and to relate the findings to histopathology and longterm survival.
Methods: Body composition was measured 1 day before a WP for ductal PCa in 36 patients (15 men,
21 women) aged 41–81 years. Results for total body nitrogen (TBN), nitrogen index (NI), total body water
(TBW), fat mass (FM) and total body potassium (TBK) were compared with results in 73 age- and
sex-matched controls. Patients' survival and details from histopathology synoptic reports were
documented.
Results: Patients undergoing WPs had low TBK values (P < 0.001) and females had lower body fat (P =
0.007) compared with controls. Five of 36 presented with significant protein deficiency, but this was not
associated with a prolonged length of stay or reduced survival. The 12 patients who had involved surgical
margins had larger tumours and reduced weight (P = 0.015), FM (P = 0.001), TBN (P = 0.045), TBK (P =
0.014) and survival (P = 0.036). However, multivariate Cox's regression analysis only included FM along
with vascular invasion and margin status as independent predictors of survival.
Conclusions: PCa patients undergoing a WP have reduced body fat and TBK compared with com-
munity controls while those with stage III tumours had greater deficits of fat, TBK and protein stores.
However, preoperative body composition was a poor predictor of postoperative survival after pathological
data were considered.
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Introduction
Pancreatic cancer is associated with weight loss and nutritional
impairment which influence inpatient morbidity and mortality.1
Despite this, the perioperative mortality rate of patients undergo-
ing Whipple’s procedure (WP) has declined in recent years, with
reports in the literature indicating significantly lower mortality
rates in more experienced centres (3.8%) compared with those in
less experienced centres (7.5–17.6%).2 Cameron et al.3 reported
an exceptional series of 1000 cases operated over a 34-year period
of practice in which mortality was as low as 1%, indicating that a
safe operation can be offered to these patients when the procedure
is undertaken by experienced surgeons in well-equipped hospitals.
This has now become the standard of care that patients expect.
Now that low rates of operative mortality have been consis-
tently achieved, longterm survival has become a more important
endpoint to study. Ahmad et al.4 have demonstrated 5-year sur-
vival of 19% and 7-year survival of 11% after WP, confirming the
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fact that resection in patients with pancreatic adenocarcinoma
(PCa) can result in relatively longterm survival, especially when
combined with adjuvant therapies. Others have repeated these
findings.2,5 Furthermore, in a study of longterm outcome results, a
significant 5-year survival advantage was reported in high-volume
centres operating on more than 25 cases per year.6 In such centres,
5-year survival after surgical resection ranges from approximately
10% to almost 30%,7–9 probably as a result of patient and cultural
variability. In a surgical study, cachexia, defined as a loss of >10%
of pre-illness weight, was associated withmore advanced disease.10
Cachexia in pancreatic cancer patients was also associated with
greater reductions in body fat as measured by computerized
tomography (CT) scanning and this resulted in reduced survival.
Resection rate was also reduced in patients with as little as 5%
weight loss, but was more substantial in those with >10% weight
loss.10
Recognized negative prognostic factors of PCa include a poorly
differentiated tumour, involved surgical margins, lymph node
involvement and tumour diameter >2 cm.7–9 In the large series
reported by Cameron et al., involved surgical margins and lymph
node metastases had negative influences on survival.3 Preopera-
tive weight loss and malnutrition, as assessed by body mass index
(BMI), have also been shown to influence longterm survival.11
This paper reports the body composition of patients presenting
for WP with the diagnosis of PCa and tests the hypothesis that
these measures are the most sensitive at detecting early cachexia
which may have an impact on longterm survival. This study uses
body composition analysis techniques which utilize the nuclear
physics technology of in vivo neutron capture analysis (IVNCA),12
total body potassium (TBK)13,14 and anthropometric techniques15
to measure the metabolically active compartments of the body
and to relate these to the stage of the tumour at diagnosis and to
survival. As histopathological factors are known to be important
predictors of survival, their role in evaluating the effect of body
composition on survival is included in this study.
Materials and methods
Patients
Patients presenting with masses in the pancreatic head in which
surgical resection by WP was indicated were invited to undergo
body composition studies prior to surgery. All WPs were per-
formed by RCS, whose operative policy was to take the renal
fascia behind the head of the pancreas and the anterior fold of the
pancreatic fascia up to the superior mesenteric artery, where
neural tissue was cleared from the right-hand side, to give the best
chance of clear margins at tumour resection. Nutritional support
was provided in the postoperative period with total parenteral
nutrition until the introduction of oral intake. During this period
17 WP patients who also underwent preoperative body compo-
sition measurements were excluded from the analysis because
their pathology was not pancreatic ductal adenocarcinoma. They
had a wide variety of pathologies, including islet cell tumours,
duodenal carcinoma, cystadenoma, chronic pancreatitis and
cystadenocarcinoma.
Blood values were recorded from the hospital pathology record
with the mean and standard deviation (SD) calculated for each.
Assessment of nutritional risk of complication (ANSB) was
computed from values for haemoglobin, lymphocyte count and
albumin.16
For the purposes of survival analysis, the patients were followed
up for 72 months postoperatively and death was chosen as the
endpoint.
The study was approved by the Royal North Shore Hospital’s
Medical (Human) Research Ethics Committee and the Radiation
Safety Committee. All subjects gave informed, written consent to
their participation in the study.
Body composition analysis
Body composition measurements were carried out 1 day before
surgery and included total body nitrogen (TBN), total body water
(TBW), total body potassium (TBK) and percentage body fat
(%BFat). Anthropometric measurements included skin-fold
thicknesses, circumferences (chest, waist, mid-thigh, mid-calf and
mid-upper arm), height and weight. The equations of Durnin and
Womersley15 were then used to estimate the %BFat from skin-fold
thickness measurements. Lean body mass (LBM) and total body
fat (TBF)/fat mass (FM) were then calculated from weight and
%BFat.
Total body nitrogen was measured non-invasively using the
IVNCA technique.12 In this technique, a small dose of radiation of
<0.2 mSv of fast neutrons was delivered to the patient. The overall
radiation received by the patient was approximately 10% of
annual background radiation. Nitrogen index (NI) was also cal-
culated by expressing TBN as a percentage of that in age-, sex- and
height-matched controls.17 These measures allowed the assess-
ment of TBN with a precision and accuracy of 97.0% and 95.5%,
respectively. An NI value of 0.95–1.05 (or 95–105%) is considered
to be within the normal range and generally patients with an NI
value of <0.95 are considered to be malnourished.
Total body water measurements were carried out directly after
TBNmeasurements while the patient was still on the IVNCA bed.
Values for TBW were obtained using the bioelectrical impedance
analysis (BIA) technique. These measurements were carried out
with the patient in the supine position using two leads attached to
the non-dominant hand and two leads attached to the ipsilateral
foot (tetrapolar arrangement). The body’s resistance was then
measured in triplicate using a swept frequency bioelectrical
impedance meter (SEAC® SFB23; UniQuest Pty Ltd, Brisbane,
Qld, Australia). The 50-kHz measurements used the equations of
Kushner and Schoeller18 to calculate the patient’s TBW. The phase
angle (PhA) was determined by the equations of Cohn et al.19 The
PhA is derived from the resistance and reactance measurements
obtained from BIA and is considered indicative of cellular health
and membrane integrity.
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Total body potassium was measured using supine geometric
sodium iodide whole body counting.13,14 This test relies on the
natural K radiation from the body to estimate TBK. The TBK
was then used to estimate the patients’ fat-free mass (FFM)
on the assumption that the potassium content of FFM is
2.26 g/kg and 2.52 g/kg in women and men, respectively.19 The
precision and accuracy of this technique are 98.5% and 95.5%,
respectively.14
Data for two age- and sex-matched control subjects for each
patient, accumulated over 15 years, were employed as community
controls. Controls were selected by excluding normal individuals
aged <41 years. Control subjects’ ages ranged from 41 to 85 years.
Descriptive pathological assessments were undertaken prospec-
tively by three pathologists. In addition, the archived slides from
all cases were subsequently reviewed by one specialist pathologist
(AJG) and placed into a synoptic format.20 Tumours were graded
using the TNM (tumour, node, metastasis) grading system21 into
four categories ranging from grade 1 (well differentiated) to grade
4 (undifferentiated). Tumours were also assigned a pathological
stage using the American Joint Committee on Cancer staging
scheme (6th edition, 2002).21 The resection margins were placed
into three categories: definitively involved (malignant cells present
at the margins); close and likely to be involved (malignant cells at
<1 mm of the margin), and clear (malignant cells >1 mm from all
margins).
Statistical analyses
All acquired data and results were stored electronically in
Microsoft FoxPro® and Microsoft Access® 2003 databases. Data
manipulation and statistical analyses were carried out in
Microsoft Excel® 2003 and spss®Version 14 forWindows® (SPSS,
Inc., Chicago, IL, USA).
Preoperative values for each of the sex-matched groups were
compared using Student’s t-test. A general linear model (GLM)
was undertaken to compare body composition results between
controls and PCa patients using sex as a fixed factor and to
compare baseline values between patients with involved and clear
surgical margins using sex as a fixed factor.A P-value of0.05 was
taken to be significant. Kaplan–Meier survival analysis using the
log-rank and Breslow (generalWilcoxon) tests for significance was
used to compare survival data between groups. Cox’s regression
was carried out to investigate the proportional hazards of different
histological factors and body composition parameters when a
log-rank or univariate analysis indicated a potential influence on
survival (P < 0.25).
Results
A total of 36 patients with pancreatic ductal adenocarcinoma
scheduled for WP underwent preoperative body composition
studies. They included 15 men and 21 women with a median age
of 71.4 years (range 41.0–81.6 years), whose median hospital stay
was 16 days (range 10–24 days). Preoperative values (mean SD)
for serum albumin (37  6 g/l), white cell count ([7.2  2.5] ¥
106/l), lymphocyte count ([1.61 0.61] ¥ 109/l) and haemoglobin
(122  31 g/l) were within the normal range, whereas that for
serum bilirubin was elevated to 108 114 mmol/l. The automated
nutritional score (ANSB) indicated increased risk for morbidity in
only five patients, in whom two or more of the above markers
showed depressed values. Postoperative hospital stay was not pro-
longed in these patients. Preoperative body composition studies
indicated that values for weight, LBM and TBN were similar to
those for the sex- and age-matched controls, but mean TBK and
TBK/Ht values were significantly lower in PCa patients (P <
0.001). Mean %BFat values were lower in female patients (P =
0.007) compared with their controls, but not in the cohort of male
patients (Table 1). Patient BMI values ranged from 15.9 kg/m2 to
39.7 kg/m2 (median 23.7 kg/m2) and did not differ from control
values.
Table 1 Body composition values in women and men with pancreatic cancer compared with those in sex- and age-matched community
controls
Women Men
Controls, n = 40 PCa patients, n = 21 P-value Controls, n = 33 PCa patients, n = 15 P-value
Mean SD Mean SD Mean SD Mean SD
Age, years 66.2 9.7 70.7 10.6 0.12 62.6 10.8 63.4 13.2 0.82
%BFat, % 37.3 4.7 32.5 7.6 0.007 26.4 5 26.2 5.9 0.85
BMI, w/h2 26 4.4 24.2 3.2 0.12 25.9 2.7 25.4 5.9 0.72
LBM, kg 40.5 5.9 38.1 5.2 0.13 57.6 7.4 56.3 9.3 0.60
TBN, g 1411.6 237.6 1350.4 236.3 0.36 2245.3 397.3 2274.6 620.1 0.84
NI 1.01 0.14 0.99 0.14 0.58 1.06 0.15 1.06 0.26 0.97
TBK, g 93.7 15.6 75.7 13.1 0.001 147.6 26 130.4 24.2 0.001
TBK/Ht, g/m 0.578 0.086 0.480 0.071 0.001 0.847 0.135 0.748 0.131 0.001
PCa, pancreatic adenocarcinoma; SD, standard deviation; %BFat, percentage body fat; BMI, body mass index; LBM, lean body mass; TBN, total
body nitrogen; NI, nitrogen index; TBK, total body potassium; TBK/Ht, total body potassium/height
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Histopathology details
Three of 36 patients had tumours in the periampullary region of
the pancreas. Twelve of 36 patients had definitive histological
evidence of incomplete excision with malignant cells at the
margins of resection (i.e. involved). In an additional three patients
the retroperitoneal margin was close (carcinoma <1 mm of the
margin). The tumours’ median maximal diameter was 30 mm
and poor prognostic features included: nodal spread (n = 25);
perineural invasion (n = 23), and vascular invasion (n = 18). In
half the patients the tumours were at least stage IIB and were grade
3 or 4 (poorly differentiated or undifferentiated). Spearman’s cor-
relation coefficients indicated significant correlations between
margin involvement and tumour size (P = 0.018). Vascular inva-
sion was associated with tumour size (P = 0.033), tumour grade (P
= 0.004) and nodal involvement (P = 0.044).
There was a significant but weak influence of margin involve-
ment on survival, whereas the influence of vascular invasion was
more definite when Kaplan–Meier survival curves were examined
(Figs 1 and 2). The tumours were 27.7  11.3 mm in diameter
when the margins were uninvolved and 35.0  9.7 mm when the
margins were involved (t = 2.22, P = 0.03). Cox’s stepwise regres-
sion analysis indicated independent influences of vascular inva-
sion and margin involvement on survival for which the hazard
ratio (HR) and confidence interval (CI) were 0.21 and 0.06–0.52
(P = 0.001), and 2.85 and 1.24–6.54 (P = 0.013), respectively.
Nutritional indices and margin status
Patients with clear and involved surgical margins had similar ages
(Mann–Whitney test, P = 0.6) and preoperative values for
albumin, haemoglobin, lymphocyte count and bilirubin. There
was no difference in hospital stay between the clear margin group
(median 17.0 days, range 14–24 days) and those with involved
surgical margins (median 17.8 days, range 10–30 days) (Mann–
Whitney test, P = 0.9).
Body weight was found to be reduced in subjects with involved
surgical margins (P = 0.015) when sex was included as a factor in
the GLM program. Both the LBM and FM measurements were
also reduced in patients with involved surgical margins: TBK (P =
0.014); TBK/Ht (P = 0.02); TBN (P = 0.045); FM (P = 0.005);
%BFat (P = 0.004); TBW (P = 0.019), and LBM (P = 0.009)
(Table 2).
Influence of preoperative nutritional status on
longterm survival
None of the measures of body composition had an influence on
survival when tested by univariate analysis: weight (P = 0.22);
LBM (P = 0.16); FM (P = 0.17), and TBN (P = 0.11). Kaplan–
Meier curves were examined to compare survival of patients with
NI values <0.95 with survival of those with NI values >0.95
(Fig. 3). There was no influence of a low NI on longterm survival.
Cox’s backward stepwise regression analysis also failed to demon-
strate influence of body composition indices, serum bilirubin (P =
0.12) and white blood cell count (P = 0.12).
Interaction of nutritional status and histopathology
on survival
Pathological indices which had a significant influence on survival
in multivariate Cox’s regression (vascular invasion, margin
involvement and posterior margin) were tested with the
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Figure 1 Kaplan–Meier survival curves for the effect of vascular inva-
sion on survival. The broken line indicates cases with vascular inva-
sion by tumour. Log-rank significance: P = 0.004
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Figure 2 Kaplan–Meier survival curves for the effect of involved sur-
gical margins on survival. The broken line indicates cases with
involved surgical margins. Log-rank significance: P = 0.048
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nutritional measures which demonstrated potential influence on
survival. There was an independent predictive effect of vascular
invasion (P = 0.010), margin involvement (P = 0.001) and FM (P
= 0.039) (Table 3). Although interaction effects demonstrated
trends, these did not reach significance at the P = 0.05 level. There
was no improvement in the equation when age and sex were
included.
Discussion
Although the WP was undertaken with the intent to improve
survival, only four of 36 patients remained alive at the end of 6
years. This reflects the aggressive nature of pancreatic cancer, but
allows for the study of influencing factors as most patients reached
the study endpoint. This study focuses on detailed body compo-
sition measurements taken at the time of presentation for surgery.
Such measures are difficult to obtain in patients with severe illness
when they are confronted with the need for major surgery.
However, the body composition findings of this study demon-
strated that total body fat and potassium, but not protein, were
reduced in patients presenting for resection of PCa compared
with community control subjects. These findings reflect the early
Table 2 The significance of involved surgical margins and preoperative body composition measures for women and men with pancreatic
cancer
Body composition
measures
Margin
status
Women Men P for multivariate
analysisn Mean SEM n Mean SEM
Weight, kg Involved 6 53.8 3.5 7 69.2 6.1 0.015
Clear 15 62.2 2.6 8 86 6.9
TBN, g Involved 6 1264 92 7 1993 189 0.045
Clear 15 1385 62 8 2531 238
NI units Involved 6 1.01 0.07 7 0.96 0.08 NS
Clear 15 0.99 0.03 8 1.16 0.1
%BFat, % Involved 6 26.3a 2.9 7 22.8a 1.8 0.004
Clear 15 35 1.7 8 29.2 2.1
FM, kg Involved 6 14.5a 2.3 7 16.4 2.8 0.005
Clear 15 22.1 1.8 8 25.9 4
TBW, kg Involved 6 25.8a 1.2 7 35.9 2.4 0.019
Clear 15 29.1 0.7 8 39.1 1.3
BMI, g/h2 Involved 6 23.2 1.4 7 23.1 2.1 NS
Clear 15 24.6 0.8 8 27.7 2.1
TBK, g Involved 6 65.3b 4.1 7 120.7 10.5 0.014
Clear 15 79.8 3.1 8 138.5 7.3
TBK/Ht, g/m Involved 6 0.43a 0.02 7 0.7 0.06 0.02
Clear 15 0.5 0.02 8 0.79 0.04
LBM, kg Involved 6 34.4a 2 7 52 3.2 0.009
Clear 15 39.6 1.2 8 60.1 3.3
P for multivariate analysis used the GLM program with sex as a fixed factor
Comparison of means within sex subgroup using t-test: aP < 0.05; bP < 0.001
SEM, standard error of the mean; NS, not significant; TBN, total body nitrogen; NI, nitrogen index, %BFat, percentage body fat; FM, fat mass; TBW,
total body water; BMI, body mass index; TBK, total body potassium; TBK/Ht, total body potassium/height; LBM, lean body mass
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Figure 3 Kaplan–Meier survival curves for the effect of nitrogen
index (NI) on survival. The broken line indicates NI < 0.95. Log-rank
significance: P = 0.44
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nutritional effects of PCa as a consequence of the complex altered
metabolism of cachexia and reduced pancreatic enzyme produc-
tion for digestion of food. These patients had not developed severe
cachexia. Only five of the 36 patients had evidence of protein
deficiency, with low NI values indicating malnutrition, and five
patients were considered to be at risk of malnutrition-related
complications according to their ANSB scores. However, these five
apparently malnourished patients did not have an increased
length of hospital stay.
Univariate analysis and histopathology results confirmed the
influence of margin status, intravascular spread, number of lymph
nodes involved and tumour size on survival. Surgical margin
involvement and vascular invasion demonstrated the strongest
independent significance on multivariate Cox’s regression. It was
interesting that patients with involved surgical margins had sig-
nificant reductions in body fat and LBM as shown by reduced
TBK, indicating that they had significantly greater reductions in
nutritional status. When Cox’s regression was undertaken on the
significant histological and body composition factors, survival was
predicted by the independent influences of margin status, vascular
invasion and fat mass, indicating that tissue reserves, complete
removal of the tumour and the aggressive nature of the cancer
play independent roles which determine survival.
A recent study which analysed CT scans taken at the time of
work-up for surgery also demonstrated that patients with pancre-
atic cancer have reduced body fat. Furthermore, patients who lose
>10% of their body weight were more likely to have metastatic
disease and thosewhohad resectionhad reduced survival.10Muscle
size did not differ between groupswith greater or lesser amounts of
weight loss. This measurement may be difficult to obtain because
water retention associated with weight loss masks changes in
protein loss.10 Nonetheless, the findings of this recent study10 are
consistent with those of the present study in that PCa patients were
more likely to have reduced body fat. Furthermore, those with
greater amounts of fat loss had reduced longterm survival.
The interpretation of nutritional status at the time of presen-
tation of PCa is complicated because of aetiological associations
with both under- and over-nutrition, as demonstrated by the wide
range of BMI values in our PCa patients. This is an important
issue because obesity is more common in our community and has
been shown to influence the onset of pancreatic cancer.22 The
Japanese Collaborative Cohort Study for Evaluation of Cancer
Risk studied 110 792 Japanese men and women enrolled between
1988 and 1990, of whom 402 developed pancreatic cancer.22 The
authors analysed data on height and weight at baseline and at 20
years of age, as well as information relating to physical activity.
Table 3 Prediction of longterm survival by histological measures and body composition in patients with pancreatic cancer
Value Cox's regression analysis
Univariate
probability
Multivariate
probability
HR and 95% CI for Cox's
multivariate analysis
Stage, n 0.740
IA 3
IB 1
IIA 14
IIB 16
III 2
Grade, n 0.074
1 1
2 20
3 13
4 2
Margin involved, n 12 0.048 0.001 0.22 (0.09–0.51)
Posterior margin, n 15 0.081
Neck margin, n 3 N/A
Neural spread, n 23 0.275
Intravascular spread, n 18 0.004 0.010 2.96 (1.29–6.80)
Lymph node metastases, n 25 0.380
Number of involved nodes, median (range) 1 (0–9) 0.047
Tumour size, mm, median (range) 30 (5–50) 0.013
Fat mass, kg, mean (SD) 20.8 (8.5) 0.130 0.039 1.06 (0.09–0.51)
TBN, g, mean (SD) 1.80 (0.20) 0.041
HR, hazard ratio; 95% CI, 95% confidence interval; N/A, not applicable; SD, standard deviation; TBN, total body nitrogen
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The relative risks of pancreatic cancer mortality were 3.5-fold
greater for men and 1.6-fold greater for women when their BMI
was30 kg/cm2. It is also interesting that in men a weight loss of
5 kg was associated with increased risk for pancreatic cancer,
whereas in women this implied a decreased risk for pancreatic
cancer. The authors concluded that the risk of pancreatic cancer in
relation to BMI seems to differ according to sex and the period
over which BMI is measured.22
Obesity, as well as malnutrition, may also have an influence on
the outcome of pancreatic cancer. House et al.23 demonstrated
that obesity, as determined by the thickness of the retro-renal fat,
was associated with increased risk for complications following
a WP. Alternatively, this paper finds that fat stores have a small
but significant influence by which increased fat stores improve
survival.
There is little information in the literature describing the effects
of body composition on survival following a WP. One of the few
available reports is by Gupta and Ihmaidat,24 who, as part of a
report on the nutritional effects of upper gastrointestinal cancer,
describe the results of short-term (7-day) body composition
changes following a WP. The authors suggest that body composi-
tion may be a useful tool for assessing surgical outcomes. An
example of the power of this concept is indicated by the finding
that the longterm consequences of a standard WP resulted in
more loss of body fat than a pylorus preserving pancreatectomy.25
Unfortunately these authors did not follow their patients from the
time of surgery and the two cohorts were studied over different
time periods, making comparisons difficult. However, the authors
of the later study concluded that pylorus preservation seems to
have advantages in terms of enduring functional and nutritional
status years after surgery for pancreatic cancer.25
Whereas some studies fail to demonstrate the advantage of good
margin clearance,26 others have demonstrated that a clear resection
margin is themost important predictor of outcome.8,9,27–31 There is
now definitive evidence that the traditional histopathological
approach to reporting pancreatic cancer margins considerably
underestimates the true high rate of margin positivity.5,6,8,27–35 For
example, when resected cancers are carefully assessed by an expe-
rienced pancreatic pathologist paying particular attention to
margin status, the rate of histologically reported incomplete exci-
sions in WP may rise from as little as 14–59% to as much as
53–85%.34,35 In these studies, in which the margins are carefully
assessed, excision status is a highly significant predictor of survival.
Our results demonstrating a relationship between margin status
and survival confirm these findings.29 Our additional finding, that
vascular invasionwas a stronger independent predictor of survival,
supports the concept that the biology of individual tumours, as
reflected by their ability to show vascular space invasion or their
degree of independent growth, is a key factor in survival. Indeed, it
is clear that the prognosis for patients who do undergo pancreatic
resection is determined by multiple factors, including both the
pathological stage and themolecular characteristics of the resected
tumour specimen.8 Longterm survival occurs only in patients in
whom the tumour is completely resected and is also influenced by
tumour classification, tumour differentiation, blood loss during
surgery, nutritional status and systemic adjuvant/neoadjuvant
therapy.26,30,31,36,37
Nutritional consequences of surgery resulting in weight loss are
also important for longterm outcome.38 Given that our patients
presented with good nutritional status and that few demonstrated
severe protein deficiency, it will be difficult to identify patients at
risk of short prognosis from body composition status at the time
of presentation. Bioelectrical impedance analysis, which is a
measure of TBW and TBF, provides a bedside measure of nutri-
tional status. The phase angle, which is derived from BIA mea-
sures, has been found to be associated with nutritional status39 and
to be an independent predictor of postoperative complications.40
It has also been shown to predict survival in patients with
advanced pancreatic cancer,39 breast cancer41 and colorectal can-
cer.42 However, we were not able to confirm this finding in our
cohort of patients.
Surgery, when possible, is considered to give a survival benefit,38
but more advanced tumours with higher TNM stage and those in
the pancreatic body are associated with poor survival. Because the
majority of these patients will also receive chemotherapy, it is
useful to examine the effect of weight loss on the outcome of
chemotherapy because it usually leads to a reduced dose and an
increased incidence of complications.38 A study of 1555 upper
gastrointestinal cases43 demonstrated that patients with weight
loss received lower chemotherapy doses initially, but this did not
prevent them from developing more frequent and more severe
dose-limiting toxicity, specifically plantar-palmar syndrome and
stomatitis, than patients without weight loss. Consequently,
patients with weight loss on average received 1 month less treat-
ment. Weight loss correlated with shorter failure-free and overall
survival, and decreased response, resulting in poorer quality of life
and performance status. Weight loss at presentation was an inde-
pendent prognostic variable with an HR of 1.43.44 The poorer
outcome from treatment in patients with weight loss appears to
occur because they receive significantly less chemotherapy and
develop more toxicity, rather than because there is any specific
reduction in tumour responsiveness to treatment.44 However,
there are multiple other factors to consider. Previous studies in
patients undergoing neoadjuvant therapy for breast cancer dem-
onstrated that NI was the best predictor of complications from
chemotherapy, resulting in a delay and reduction in treatment.17
Marechal et al.38 devised a prognostic index which includes aspar-
tate transaminase >53 IU/l, weight loss10% of body weight and
Karnofsky performance status <90 as significant independent
negative prognostic factors for first-line gemcitabine chemo-
therapy.38 Fearon et al.44 examined 170 patients and demonstrated
that a three-factor profile incorporating weight loss (10%),
low food intake (1500 kcal/day) and systemic inflammation
(C-reactive protein 10 mg/l) was a better predictor of adverse
events and of the patient’s overall prognosis than weight loss
alone.
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Conclusions
In conclusion, this paper documents the detailed body composi-
tion status of patients presenting with resectable PCa and indi-
cates that those with larger tumours and involved margins present
with greater losses of body fat and lean tissue. Fat mass at presen-
tation had a weak, but significant, predictive effect on survival.
However, only a small percentage of patients presented with severe
cachexia. In these patients its influence on hospital stay and sur-
vival was not evident. Furthermore, the pathological criteria of
margin status and vascular invasion appear to have stronger influ-
ences on survival. Therefore, when a patient presents with signifi-
cant weight loss, the doctor should be alerted to the association
with amore advanced cancer and the patient should not be denied
surgical treatment if the radiological characteristics indicate that
clear margins can be achieved.
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